Group 1 - Daqian Ecological announced the resignation of Chairman Zhang Yuan due to personal reasons, affecting his roles in the board and strategic committee [1] - Daqian Ecological, established in October 1988, focuses on urban renewal, rural revitalization, and ecological restoration [1] Group 2 - Haili Biological plans to use up to 500 million yuan of idle funds to invest in financial products issued by banks, brokers, trusts, and fund companies [1] - Haili Biological, founded in July 1981, specializes in in vitro diagnostic reagents and oral tissue repair and regeneration materials [1] Group 3 - Xianglou New Materials' application for a private placement of shares has been accepted by the Shenzhen Stock Exchange [2] - Xianglou New Materials, established in December 2005, is engaged in the research, production, and sales of customized precision stamping new materials [3] Group 4 - Zhuochuang Information has submitted an application for H-share listing to the Hong Kong Stock Exchange [4] - Zhuochuang Information, founded in April 2004, provides market data monitoring, trading price evaluation, industry data analysis, and research [4] Group 5 - Zhongwei Company plans to reduce its shareholding by up to 626,150 shares, representing 1% of the total share capital [5] - Zhongwei Company, established in May 2004, focuses on the research, production, and sales of high-end semiconductor equipment and related products [5] Group 6 - Jiarong Technology intends to raise up to 1 billion yuan through a private placement to acquire 100% of Hangzhou Lanran [6] - Jiarong Technology, founded in February 2005, specializes in membrane separation equipment and high-performance membrane components [6] Group 7 - Dameng Data's director and general manager Pi Yu has had his detention lifted by the local supervisory committee [7] - Dameng Data, established in November 2000, provides various database software, cloud computing, big data products, and related technical services [7] Group 8 - Huayang Co. has launched a 200-ton annual production project for high-performance carbon fiber [8] - Huayang Co., founded in December 1999, is involved in coal production, power generation, and renewable energy technologies [8] Group 9 - Saintno Biological's executives plan to collectively reduce their holdings by up to 37,600 shares, which is 0.024% of the total share capital [9] - Saintno Biological, established in July 2001, focuses on the research, production, and sales of peptide raw materials and formulations [9] Group 10 - *ST Dongyi is in the process of signing a comprehensive technical service agreement worth 635 million yuan [10] - *ST Dongyi, founded in November 1996, provides comprehensive home decoration services [11] Group 11 - Jiangxi Copper is attempting to acquire all shares of London-listed SolGold, with a recent offer of 26 pence per share [12] - Jiangxi Copper, established in January 1997, specializes in copper and gold mining, smelting, and processing [12] Group 12 - China Shenhua's subsidiary has successfully completed a 168-hour trial run of its power generation unit [13] - China Shenhua, founded in November 2004, is involved in coal and electricity production and sales [13] Group 13 - Baile Tianheng's subsidiary has received a milestone payment of 250 million USD from BMS [14] - Baile Tianheng, established in August 2006, focuses on innovative biopharmaceuticals and chemical preparations [14] Group 14 - Yulide's directors plan to reduce their holdings by up to 35,000 shares, representing 0.0313% of the total share capital [15] - Yulide, founded in December 2003, specializes in the research, production, and sales of testing and measuring instruments [15] Group 15 - Aters plans to establish joint ventures with its controlling shareholder to adjust its U.S. market operations [15] - Aters, established in April 2006, focuses on lithium-ion battery separator products and sterile packaging [15] Group 16 - Enjie Co. is planning to acquire 100% of Zhongke Hualian's shares, leading to a stock suspension [16] - Enjie Co., founded in April 2006, specializes in lithium-ion battery separator products and sterile packaging [16] Group 17 - ST Tianrui's controlling shareholder is planning a change in company control, resulting in a stock suspension [16] - ST Tianrui, established in July 2006, focuses on analytical testing instruments and environmental governance [17]

Core Viewpoint - ST Tianrui (SZ300165) is planning a change in control, which may lead to a shift in its major shareholder and actual controller, Liu Zhaogui, who currently holds 20.37% of the company's shares [2][3][6]. Group 1: Control Change Announcement - Liu Zhaogui, the founder and actual controller of ST Tianrui, is in the process of planning a change in the company's control, with the stock being suspended from trading starting December 1, 2023, for no more than two trading days [2]. - The transaction related to the control change is still uncertain, as no agreements have been signed, and discussions regarding the specific transaction plan are ongoing [3]. Group 2: Regulatory Issues and Penalties - ST Tianrui has been under risk warning since December 2024 due to violations related to revenue recognition, leading to a warning and fines totaling 3 million yuan for the company and additional fines for Liu Zhaogui and other executives [3][7]. - The previous attempt to change control was halted due to an investigation by the China Securities Regulatory Commission (CSRC) [4]. Group 3: Financial Performance - ST Tianrui's financial performance has been declining, with revenue dropping to 851 million yuan in 2024, only 55.2% of its 2021 revenue, and a cumulative net loss of 354 million yuan since 2021 [7]. - The company specializes in analytical testing instruments and environmental governance, with core products including spectrometers and chromatographs [7].

登录新浪财经APP 搜索【信披】查看更多考评等级 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导性陈述或重大遗 漏。 特别提示： 1、江苏天瑞仪器股份有限公司（以下简称"公司"）控股股东、实际控制人刘召贵先生正在筹划公司控 制权变更相关事宜，该事项可能导致公司控股股东及实际控制人发生变更。为保证公平信息披露，避免 公司股价异常波动，维护广大投资者利益，经公司向深圳证券交易所申请，公司股票（股票简称：ST 天瑞，股票代码：300165）自2025年12月1日（星期一）开市起停牌，预计停牌时间不超过2个交易日。 江苏天瑞仪器股份有限公司董事会 二○二五年十二月一日 公司今日收到控股股东、实际控制人、董事长刘召贵先生出具的《关于筹划公司控制权变更事项的告知 函》，获悉刘召贵先生正在筹划公司控制权变更相关事宜，目前各方尚未签署相关协议，拟就具体交易 方案、协议等相关事项进行论证和磋商，具体情况以各方签订的相关协议为准。 鉴于上述事项尚存在重大不确定性，为保证公平信息披露，避免造成公司股价异常波动，维护广大投资 者利益，根据《深圳证券交易所上市公司自律监管指引第6号一一停复牌》相关规定，经 ...

今年3月，ST天瑞收到《行政处罚决定书》，相关违法事实认定与《行政处罚事先告知书》一致。基于 前述情况，公司被给予警告，并处以300万元罚款，相关责任人均被给予警告，并处60万元至100万元不 等的罚款。 需要关注的是，ST天瑞针对违法事项已进行整改，并对2021年年报进行了会计差错更正及追溯调整。 截至目前，公司不存在尚未整改完毕的事项。 ST天瑞主营分析检测仪器、环境治理等业务，其中实验分析仪器为公司核心产品，主要产品涵盖光谱 仪、色谱仪、质谱仪等三大类分析仪器，广泛应用于电子电器、珠宝首饰、材料分析、石油化工、食品 安全、环境保护、地质勘探、科学研究等诸多行业的有机成分、无机成分快速筛查及精准检测。 近年来，受行业竞争加剧等因素影响，ST天瑞营收逐年下滑，净利润已连续多年处于亏损状态。今年 以来，公司持续聚焦主业，逐步优化非盈利资产，剥离PPP项目，前三季度实现营业收入4.35亿元，同 比下降26.15%；归母净利润为亏损121.79万元，虽然仍处于亏损状态，但亏损幅度同比显著收窄。 除主业存在扭亏压力外，ST天瑞当前正被实施其他风险警示。2024年12月，公司收到中国证监会出具 的《行政处罚事先告知书 ...

Major Events - Enjie Co., Ltd. is planning to acquire 100% equity of Zhongke Hualian and will suspend trading starting December 1, 2025 due to uncertainties surrounding the transaction [4] - ST Tianrui's controlling shareholder is planning a change in company control, leading to a trading suspension starting December 1, 2025, expected to last no more than two trading days [5] - Jiarong Technology intends to raise no more than 1 billion yuan through a private placement and acquire 100% of Hangzhou Lanran [6][7] - Baili Tianheng's wholly-owned subsidiary received a milestone payment of 250 million USD from BMS related to a collaboration agreement [8] - Jiangxi Copper is planning to acquire shares of the overseas listed company SolGold Plc, with a non-binding cash offer of 26 pence per share, currently in the informal offer stage [9] - China Shenhua's subsidiary successfully completed a 168-hour trial run of its power generation unit, marking a significant milestone in its expansion project [10] - ST Dongyi faces the risk of bankruptcy due to unsuccessful restructuring efforts, which could lead to stock delisting [11] - Huayang Co., Ltd. has launched a high-performance carbon fiber project with an annual production capacity of 200 tons, applicable in various high-tech fields [12] - Dameng Data's general manager has had his detention lifted by the local authorities [13] Shareholding Changes - Zhongwei Company plans to reduce its stake by no more than 1% through block trading, equating to approximately 6.26 million shares [14] - Yulide's directors plan to collectively reduce their holdings by no more than 0.0313%, totaling up to 35,000 shares [15] - Shengnuo Bio's vice president and a board member plan to reduce their holdings by no more than 0.024%, totaling up to 37,600 shares [16] Major Contracts - Aoride plans to sign a comprehensive technical service agreement with Company X, with a total contract value of approximately 635 million yuan [17]

Core Viewpoint - ST Tianrui is planning a change in company control after four consecutive years of losses, with the actual controller Liu Zhaogui initiating discussions on this matter [1]. Group 1: Company Control Change - On November 30, ST Tianrui announced that it received a notice from its controlling shareholder and chairman Liu Zhaogui regarding the planning of a change in company control [1]. - Currently, no agreements have been signed, and discussions on specific transaction plans and agreements are ongoing [1]. - Due to the uncertainty surrounding this matter, ST Tianrui has applied for a trading suspension starting December 1, 2025, for up to two trading days [1]. Group 2: Financial Performance - ST Tianrui has experienced continuous losses from 2021 to 2024, with revenue declining from 2022 to 2024 [2]. - The company's main business includes analysis and detection instruments, as well as environmental governance [2]. Group 3: Stock Information - As of November 28, ST Tianrui's stock closed at 4.64 yuan per share, with a market capitalization of 2.299 billion yuan [3].

【导读】ST天瑞实际控制人正筹划公司控制权变更事项 中国基金报记者 卢鸰 连续四年亏损的ST天瑞又要"卖壳"了。 制作：小茉 不过，2024年5月下旬，ST天瑞公告，鉴于公司融资环境发生变化，决定终止公司控制权变更事项。 ST天瑞的主要业务是分析检测仪器、环境治理等。2021年—2024年，公司连续四年亏损，2022年— 2024年营收持续下滑。 11月28日，ST天瑞股价以4.64元/股报收，最新市值为22.99亿元。 校对：纪元 ST天瑞11月30日下午公告，公司当日收到控股股东、实际控制人、董事长刘召贵出具的《关于筹划公 司控制权变更事项的告知函》，获悉刘召贵正在筹划公司控制权变更相关事宜，目前各方尚未签署相关 协议，拟就具体交易方案、协议等相关事项进行论证和磋商，具体情况以各方签订的相关协议为准。 鉴于上述事项尚存在重大不确定性，根据《深圳证券交易所上市公司自律监管指引第6号——停复牌》 相关规定，经ST天瑞向深圳证券交易所申请，公司股票（股票简称：ST天瑞，股票代码：300165）自 2025年12月1日（星期一）开市起停牌，预计停牌时间不超过2个交易日。 2023年5月12日，ST天瑞控股股东、实 ...

Core Viewpoint - ST Tianrui is planning a change in company control due to continuous losses over the past four years, indicating a potential "shell sale" [2] Group 1: Control Change Announcement - On November 30, ST Tianrui announced that its controlling shareholder and chairman, Liu Zhaogui, is planning a change in company control, with no agreements signed yet [2] - The company has applied for a trading suspension starting December 1, 2025, for up to two trading days due to the uncertainty surrounding the control change [4] Group 2: Previous Control Change Attempts - In May 2023, Liu Zhaogui signed a share transfer agreement with Guangzhou Lidu Virtual Reality Technology Partnership, aiming for a control change where Li Gang would become the actual controller [4] - However, in late May 2024, ST Tianrui announced the termination of the control change due to changes in the financing environment [5] Group 3: Financial Performance - ST Tianrui's main business includes analytical testing instruments and environmental governance, but the company has reported continuous losses from 2021 to 2024, with declining revenue from 2022 to 2024 [6] - As of November 28, the stock price was 4.64 yuan per share, with a market capitalization of 2.299 billion yuan [9]

Company Focus - Enjie Co., Ltd. plans to acquire 100% equity of Zhongke Hualian, leading to a stock suspension [2] - Canadian Solar Inc. and its controlling shareholder plan to establish a joint venture to adjust their U.S. market operations [3] - Jiarong Technology intends to acquire 100% of Hangzhou Lanan, with stock resuming trading [3] Equity Changes - ST Tianrui's controlling shareholder is planning a change in control, resulting in stock suspension [4] Shareholding Changes & Buybacks - Shanghai Chuangtou intends to reduce its stake in Zhongwei Company by no more than 1% [5] Operations & Performance - China Shenhua's subsidiary successfully completed a 168-hour trial run of its power generation unit, transitioning to commercial operation [6] - Baillie Tianheng received a milestone payment of $250 million from Bristol-Myers Squibb for the iza-bren project [7] - Jiangxi Copper is in the informal offer stage to acquire shares of SolGold Plc [8] - Aorede plans to sign a 635 million yuan computing power procurement agreement [9] - Maiwei Bio's clinical research for 9MW1911 shows significant reductions in acute exacerbation rates for COPD patients [10] - Huayang Co. has launched a high-performance carbon fiber project with an annual production capacity of 200 tons [10] Financing & Capital Increase - Ganfeng Lithium plans to issue $100 million in exchangeable notes to the China-Africa Development Fund [11] Stock Price Fluctuations - Tongyu Communications confirmed normal operations amid stock price fluctuations [12] - Rongji Software reported normal operations despite stock price declines [13] Other - Xianglou New Materials' application for a specific stock issuance has been accepted by the Shenzhen Stock Exchange [15] - JinkoSolar received a prepayment of 220 million yuan for a fire incident at its battery workshop [15] - Dameng Data's general manager has had his detention lifted [15] - Dongpeng Beverage has received approval from the CSRC for its overseas listing [16]

Core Viewpoint - ST Tianrui is undergoing a potential change in control, as announced by its controlling shareholder and chairman Liu Zhaogui, with no agreements signed yet [1] Company Overview - ST Tianrui is a high-tech enterprise with independent intellectual property, owning nine wholly-owned subsidiaries and five controlling subsidiaries, specializing in the research, production, and sales of analytical testing instruments and software [2] Financial Performance - For the first three quarters of 2025, ST Tianrui reported a revenue of 435 million yuan, a year-on-year decrease of 26.15%, and a net profit attributable to shareholders of a loss of 1.22 million yuan [2] Stock Information - As of November 28, ST Tianrui's stock price was 4.64 yuan per share, with a total market capitalization of approximately 2.3 billion yuan [3]